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Abstract 
Objectives 
To compare the sensitivity of enhancing multiple sclerosis (MS) lesions in gadolinium-
enhanced 2D T1-weighted gradient-echo (GRE) and spin-echo (SE) sequences, and to 
assess the influence of visual conspicuity and laterality on detection of these lesions. 
Methods 
One-hundred MS patients underwent 3.0T brain MRI including gadolinium-enhanced 
2D T1-weighted GRE and SE sequences. The two sets of contrast-enhanced scans were 
evaluated in random fashion by three experienced readers. Lesion conspicuity was 
assessed by the image contrast ratio (CR) and contrast-to-noise ratio (CNR). The 
intracranial region was divided into four quadrants and the impact of lesion location on 
detection was assessed in each slice. 
Results 
Six-hundred and seven gadolinium-enhancing MS lesions were identified. GRE images 
were more sensitive for lesion detection (0.828) than SE images (0.767). Lesions 
showed a higher CR in SE than in GRE images, whereas the CNR was higher in GRE 
than SE. Most misclassifications occurred in the right posterior quadrant. 
Conclusions 
The gadolinium-enhanced 2D T1-weighted GRE sequence at 3.0T MRI enables 
detection of enhancing MS lesions with higher sensitivity and better lesion conspicuity 
than 2D T1-weighted SE. Hence, we propose the use of gadolinium-enhanced GRE 
sequences rather than SE sequences for routine scanning of MS patients at 3.0T. 
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Key points 
 2D SE and GRE sequences are useful for detecting active MS lesions. 
 It remains uncertain the more sensitive of these sequences at high field. 
 In this study GRE sequence showed a better sensitivity and lesion conspicuity 
for detecting active MS lesions than SE sequence. 
 We propose to use GRE sequence rather SE sequence for detecting active MS 
lesions at 3.0T. 
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Abbreviations 
CIS  Clinically isolated syndrome 
CNR Contrast-to-noise ratio 
CR Contrast ratio 
EDSS Kurtzke Expanded Disability Status Scale 
FA Flip angle 
FN False-negative 
FP False-positive 
GRE Gradient recalled-echo 
MS Multiple sclerosis 
SE Spin-echo 
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TP True-positive 
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Introduction 
Gadolinium-enhanced magnetic resonance imaging (MRI) is currently the reference 
standard to detect active inflammatory lesions in multiple sclerosis (MS) patients [1, 2]. 
This technique has a pivotal diagnostic role in demonstrating dissemination in time 
according to the 2010 McDonald criteria [3] and is essential for assessing and predicting 
treatment response in clinical trials and clinical practice [4, 5]. The sensitivity of 
enhanced MRI to detect active lesions may vary according to the acquisition strategy 
used (eg, delay between injection and image acquisition, contrast dose, field strength, 
and frequency of MRI sampling) [1, 6, 7]. Selection of the most appropriate T1-
weighted sequence after contrast injection may also influence sensitivity. Several 
clinical studies performed at 1.5T have shown that conventional 2D spin-echo (SE) 
sequences perform better than gradient recalled-echo (GRE) sequences for depicting 
active MS lesions after gadolinium injection [8], but it remains uncertain which of these 
two sequences is more sensitive for this purpose at higher field strengths [8-11]. 
When analyzing and comparing the sensitivity of different contrast-enhanced T1-
weighted sequences to identify enhancing lesions, two concepts should be taken into 
account: visibility and conspicuity. Visibility usually refers to the intensity or salience 
of the features or properties of an object, such as the color, luminance, form, or size, 
whereas conspicuity refers to how well an object visually stands out from its 
environment [12]. In a more radiological sense, the concept of conspicuity is related to 
an attempt to objectively quantify radiologic observational error [13]. Conspicuity refers 
to how well a given feature stands out from surrounding structures, and it can be 
defined as the ratio between the lesion contrast and the complexity of the surroundings 
[13, 14]. Other factors such as visual laterality, which is based on lateral masking, a 
phenomenon in which the peripheral perception of a visual target is impaired when 
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distractors are present in the adjacent surroundings [15], can also influence lesion 
detection. 
The aims of this study were to compare the sensitivity of active MS lesion detection in 
gadolinium-enhanced T1-weighted GRE and SE sequences, determine the influence of 
visual conspicuity and laterality on detection of these lesions, and investigate whether 
the topographic distribution of the lesions has an impact on their detection. The 
hypothesis was that the use of GRE sequences would provide better lesion detection 
than SE sequences at 3.0T, as the latter sequence may result in ghosting artifacts due to 
of vessel pulsation, leading to an increase in background noise.  
 
Materials and Methods 
Patients 
Patients 18 to 50 years of age with a CIS suggestive of CNS demyelination 
unattributable to other diseases and patients with a diagnosis of relapsing MS based on 
the McDonald 2010 criteria [3] showing at least 2 brain T2 lesions of the type seen in 
MS were eligible for inclusion in the study. CIS patients were scanned within the first 3 
months after symptoms onset as part of their initial routine assessment, and relapsing 
MS patients were scanned because of suspected disease activity.  
The exclusion criteria were pregnant or nursing women, patients having a pacemaker or 
any other factor that would preclude proximity to a strong magnetic field, those with 
severe claustrophobia or a known allergy to gadolinium compounds, administration of 
steroids within the 30 days before MRI scanning, and known severe renal function 
impairment.  
The study included 100 consecutive patients (73 women; overall mean age, 35.8 years; 
range [23, 50] years), with a median Kurtzke Expanded Disability Status Scale (EDSS) 
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score of 3 (range, [0, 8]). Twenty-six patients had a CIS, and 74 a diagnosis of 
relapsing-remitting MS [3, 16]. The study was approved by the Ethics Committee of our 
institution and written informed consent was obtained from all patients for participation. 
 
MRI acquisition 
All patients were examined on a 3.0T MRI scanner (Magentom Trio, Siemens, 
Erlangen, Germany) using a 12-channel head coil. The MRI protocol followed the 
standard of practice in our institution, and included the following sequences: 
1) Transverse proton density and T2-weighted fast spin-echo (repetition time [TR], 
2500 ms; echo time [TE], 16-91 ms; voxel size, 0.78x0.78x3.0 mm
3
; flip angle [FA], 
150º; acquisitions [Acq], 2; acquisition time [TA], 4:52 min). 
2) Transverse fast T2-FLAIR (TR, 9000 ms; TE, 100 ms; inversion time [TI], 2500ms; 
FA, 120º; voxel size, 1.0x1.0x3.0 mm
3
; Acq, 1; TA, 4:14 min). 
3) Post-contrast sequences: 15 minutes after injection of a double dose of gadobutrol 
(0.2 mmol/kg), a T1-weighted GRE sequence was acquired (TR, 297 ms; TE, 2.46 ms; 
FA, 70º; voxel size, 0.78x0.78x3.0 mm
3
; Acq, 3; TA, 3:50 min). Just before GRE 
sequence acquisition in half the patients and just after in the other half, an SE sequence 
was acquired (TR, 480 ms; TE, 20 ms; FA, 90º; voxel size, 0.78x0.78x3.0 mm
3
; Acq, 1; 
TA, 5:31 min). Both sequences were acquired without activating acceleration in the 
acquisition.  
All sequences were acquired using 3-mm-thickness contiguous slices covering the 
whole brain. In our center, we routinely use a double dose of gadobutrol (0.2 mmol/kg) 
for evaluating MS patients. Our experience (unpublished data) and data from the 
literature [17, 18] have shown that this strategy increases the sensitivity of MRI for 
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detecting gadolinium-enhancing brain lesions by decreasing the T1 relaxation time 
effect.  
Image analysis 
In each set of T1-weighted sequences, three readers (R.M., E.H. and J.F.C.), with more 
than 10 years’ experience analyzing MR images in clinical studies and clinical trials 
related to MS, identified the enhanced MS lesions independently, separately, and in 
randomized order. Readers were blinded to any additional information other than the 
contrast-enhanced T1-weighted sequence they were interpreting. 
The reference standard for the enhanced MS lesions was defined by consensus between 
two of the authors (P.A. and A.R.), with 2 and more than 20 years of experience. These 
specialists did not participate in the blinded reading. They jointly reviewed the MR 
imaging datasets and had access to the clinical data, the radiological report, and all the 
MR sequences performed. An enhanced MS lesion was defined as a focal enhancement 
on post-contrast images, with a large enough size to differentiate it from its local 
background, involving gray or white matter and associated with a parenchymal 
hyperintensity on T2-FLAIR or T2-weighted images. Each MS lesion identified based 
on these criteria computed as one lesion in the reference standard, regardless of whether 
it was better or more poorly perceived in the GRE or the SE images. One of the authors 
(P.A.) then delineated each lesion in both the SE and GRE images using the 
semiautomated tool included in Jim 5.0 (Xinapse Systems Ltd, Essex, UK), which 
additionally provided the lesion volume. Qualitative information was also recorded on 
the location of the lesions (periventricular, subcortical, juxtacortical, or infratentorial), 
the contrast uptake pattern (nodular, ring, open-ring, or heterogeneous), and the lesion 
differentiability, defined as the ease with which a lesion could be identified in an image, 
graded on a 5-point scale: very poor, poor, fair, good, or excellent. 
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The lesions identified by the three readers were then compared with the reference 
standard to determine the number of true-positive (TP), false-negative (FN) and false-
positive (FP) identifications. The sensitivity values were calculated as follows: 
S=TP/(TP+FN). Using an in-house-developed program, identifications corresponding to 
TPs and FNs were matched with the lesion delineation defined in the reference standard. 
Lastly, detections corresponding to FPs were newly delineated. 
To obtain quantitative measurements related to the visual conspicuity of the lesions, the 
contrast ratio (CR) and contrast-to-noise ratio (CNR) were evaluated in each of the 
lesion detection groups (TP, FP, FN). The contrast ratio between the MS lesion and its 
background was calculated using the formula CR=(SI lesion - SI background)/SI 
background, and the contrast-to-noise ratio was calculated as CNR=(SI lesion - SI 
background)/SD noise, where SI represents the signal intensity of a region and SD noise 
the standard deviation of the noise measured in the background of the image. Two 
background 3-pixel and 5-pixel-width areas surrounding the lesions were selected, and 
4 quantitative measures to evaluate visual conspicuity were computed: CR3, CR5, 
CNR3, and CNR5. Finally, the effect of visual laterality was evaluated in each slice by 
first tracing a horizontal and vertical line crossing at the brain center and dividing the 
brain into four quadrants to establish the topographic distribution of lesions. The 
number of lesions, and the number of TP, FN, and FP detections were then computed in 
each quadrant. 
 
Statistical analysis 
Statistical analyses were performed using SPSS v13.0 software (IBM Corp., USA). 
Statistical differences in lesion counting by each reader were compared per patient using 
the Wilcoxon signed-rank test. In addition, the sensitivity values for detecting lesions in 
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both sequences were calculated for each reader and for the overall group. To evaluate 
the performance of the conspicuity indexes between the lesion detection groups, we 
used analysis of variance (ANOVA), with Dunnett’s T3 test as a post-hoc test to 
consider non-homogeneity of the variances in the groups. P-values of less than 0.05 
were considered statistically significant. Finally, we used conspicuity measurements to 
determine whether the lesion detection groups could be differentiated by their visual 
properties. The conspicuity measurements for each lesion detection group were 
classified in clusters. We then calculated the separability of the conspicuity 
measurements between detection groups using a measure of distance between clusters. 
The distance between two clusters was computed as dAB=|mA-mB|/(SDA+SDB), 
where mI and SDI were, respectively, the mean and standard deviation of the values of 
a conspicuity index for a cluster I={A, B}. According to this metric, the higher the 
value the greater the distance between two clusters, and consequently, the better the 
separability between the lesion detection groups based on visual conspicuity. 
 
Results 
Reference standard 
Following evaluation of all the available MR sequences, 607 gadolinium-enhancing MS 
lesions were found in 100 patients (mean number of lesions per patient, 6.07; SD, 
13.10; range, [0, 107]; patients without gadolinium-enhancing lesions, 38; median of 
lesions in patients with at least one gadolinium-enhancing lesion, 4), with a mean 
volume of 119.4 mm
3
 in SE images (range, [1.1, 3158.6]) and 120.5 mm
3
 in GRE 
images (range, [1.8, 3158.6]). The high percentage of patients with at least one 
gadolinium-enhancing lesion, and the high number of gadolinium-enhancing lesions 
could be explained by the fact that all patients had recent clinical activity.   
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By anatomical location, 274 lesions (45.14%) were subcortical, 165 (27.18%) 
juxtacortical, 105 (17.30%) periventricular, and 63 (10.38%) infratentorial. Most of the 
lesions found (527, 86.82%) showed a nodular pattern of contrast uptake, 13 (2.14%) 
showed a ring pattern, 34 (5.60%) an open-ring, and 33 (5.43%) were heterogeneous. In 
SE images, differentiability was rated as excellent in 251 lesions, good in 114, fair in 
94, poor in 79, and very poor in 69, whereas in GRE images, differentiability was 
considered excellent in 217 lesions, good in 142, fair in 91, poor in 70, and very poor in 
87. 
 
Effect of the order in which sequences were acquired  
In half the patients SE sequences were acquired before GRE (SE-GRE) and in the other 
half GRE sequences were acquired before SE (GRE-SE). According to the reference 
standard, the distribution of lesions was balanced: 49.9% were detected in patients 
undergoing SE sequences first and 50.1% in those undergoing GRE first. There were 
only small differences between TPs, FNs, FPs, and sensitivity according to the order in 
which sequences were acquired (Table 1). Furthermore, the sensitivity of each sequence 
increased in a similar manner when it was acquired in second place. Hence, we consider 
that there was no relevant effect of the order in which sequences were acquired on their 
performance. 
 
Agreement between readers and the reference standard 
Figure 1 shows an example of TPs, FNs, and FPs marked by readers using the two T1-
weighted sequences. On qualitative assessment, TPs varied considerably in size and 
shape, whereas FNs and FPs were usually smaller lesions. The total number of 
detections, the number of TPs, FPs, and FNs, the sensitivity values for each reader, and 
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the mean sensitivity values for the three readers are summarized in Table 2. GRE 
images had a higher number of TP detections; consequently the number of FNs was 
lower and the sensitivity higher (GRE, 0.828; SE, 0.767). The number of FP detections 
was very similar in the two sequences (SE, 2.75%; GRE, 2.69%). On patient-wise 
analysis, differences in the number of TPs between SE and GRE images were 
significant between all the readers (p=0.018, 0.013, <0.001, respectively) and 
differences in the number of FNs were significant between 2 of the 3 readers (p=0.119, 
0.041, 0.005, respectively). There were no significant differences between the readers 
for the number of FPs (p=0.702, 0.501, 0.609, respectively). 
The majority of reference standard markings were rated as having fair to excellent 
differentiability in both SE and GRE sequences, with somewhat better differentiability 
in SE images, inferred from a greater number of lesions classified as excellent in this 
sequence (Table 3). However, there were fewer FNs in GRE images than SE images. 
Moreover, the FNs in GRE images were mainly classified as having very poor 
differentiability, whereas FNs in SE images were distributed from very poor to fair 
differentiability.  
 
Visual conspicuity and laterality  
The results obtained using the conspicuity indices are shown in Table 4. Overall, the CR 
values were higher for SE images, whereas CNR values were higher for GRE images. 
Statistically significant differences in TP, FN, and FP detection were observed across all 
four indices (p-value<0.001). To select the sequence with better performance, we also 
analyzed a distance measure whose values are shown in Table 5. CNR3 measurements 
showed the highest distance between TP and FN in GRE images (dTPFN=0.612), and 
between TP and FP in SE images (dTPFP=0.550). 
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Finally, the analysis of visual laterality showed that FNs were mainly located in the 
posterior quadrants in both GRE and SE images (Figure 2). Although there were no 
large differences between the two sides, the right posterior quadrant (quadrant 2 in the 
Figure), was the region in which the largest number of FN readings occurred: 21.23% of 
lesions identified in this quadrant using the GRE sequence and 25.68% using the SE 
sequence. 
 
Discussion 
The results of this study show that the sensitivity for detecting gadolinium-enhancing 
lesions on a 3.0T system was higher with the use of 2D GRE sequences than with 2D 
SE sequences. To date, most clinical studies and trials in MS have been carried out 
using 1.5T magnets [19-21]. There is much less available data related to the use of 3.0T 
magnets, which are becoming increasingly more common in the clinical setting.  
As relates to MS, 3.0T systems offer some advantages over lower field strengths, such 
as higher detection rates for T2 and gadolinium-enhancing brain lesions [22-24], an 
important capability for diagnosing and monitoring MS patients. Some studies 
performed at 1.5T have shown that conventional 2D SE sequences are apparently better 
than GRE sequences for depicting gadolinium-enhancing lesions [8], but the most 
appropriate T1-weighted sequence for detecting these lesions at 3.0T is still a matter of 
debate.  
The findings from a previous study comparing 2D SE and GRE sequences for brain 
imaging at 3.0T (although not specifically focused on MS) suggested that GRE may be 
more sensitive for detecting contrast-enhancing lesions [25]. This is consistent with our 
results in MS lesions, and GRE has the additional advantage of a shorter acquisition 
time. 
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Another issue to take into account is the readers’ identification errors (prevalence of 
FNs versus FPs) when interpreting the two sequences. In the present study, the number 
of FPs did not reach 20% of the number of FNs, and the number of FNs was about 25% 
of the total number of lesions. SE images showed poorer performance than GRE in 
terms of FN detection. 
The qualitative approach to identify lesions seemed to provide somewhat better results 
when SE sequences were analyzed: a larger number of lesions were rated as excellent in 
this sequence according to the reference standard. Furthermore, the subjective 
differentiability of lesions defined in the reference standard seemed to be related to the 
CR. The findings on quantitative analysis, however, seem to contradict these qualitative 
results: GRE showed higher sensitivity for lesion detection and a higher CNR than SE. 
This contradiction may have arisen because the subjective approach may be more 
related to the visibility of lesions than to their conspicuity. Analysis of the CNR, which 
better assesses the complexity of the surroundings around the lesions than the CR by 
taking into account factors such as image noise, provided results that better matched the 
sensitivity values found. 
To investigate the complexity of the tissue surrounding the lesions, we introduced 2 
widths of the surrounding area for the lesion background. Nonetheless, the extension of 
this area did not seem relevant, as the results obtained for the 2 widths were very 
similar. 
In the study of the effect of visual laterality on lesion detection, we found a higher 
probability of FN detection in lesions located in the posterior quadrants than in those 
with frontal locations. Hence, detection of lesions in areas mainly located in these 
quadrants, such as the infratentorial region, may be more complex. 
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Our study has some limitations. First, the GRE and SE sequences were not acquired at 
the same time after contrast injection. To compensate for this fact, SE images were 
acquired just before acquisition of GRE images in half the patients, and just after in the 
other half. However, our analysis of this factor showed that the order in which 
sequences were acquired seemed to have no effect on the results obtained. Second, the 
study only investigated 2D sequences, as 2D sequences remain the standard performed 
in many clinical trials and research studies [26]. 3D sequences represent a potentially 
valuable alternative because a large number of thin contiguous sections can be acquired 
in a relatively short imaging time, thus providing high-resolution coverage of the 
complete volume of interest and a data set that can be reformatted to obtain high-quality 
images in any plane [27]. Recent studies have shown that at 3T, 3D GRE or 3D fast SE 
sequences provide higher detection rates for gadolinium-enhancing MS lesions, 
especially smaller ones, than standard 2D SE, and better suppress artifacts related to 
vascular pulsation [10, 11]. However, these data were published after the time when the 
present study was designed. Lastly, it was not possible to define a strict gold standard to 
determine the TP, FN, and FP rates, as subjective measurements are never absolutely 
free from error. Instead, we used a comparator reference standard established on 
consensus. It is important to stress that a lesion included in the reference standard was 
the comparator for both sequences, regardless of whether it had been better or more 
poorly perceived in each sequence; hence, the comparison can be considered valid. 
In conclusion, this study shows that the contrast-enhanced 2D T1-weighted GRE 
sequence on 3.0T MRI enables detection of enhancing MS lesions with higher 
sensitivity than the 2D T1-weighted SE sequence and provides better lesion conspicuity. 
Because of the important role of MRI in diagnosing MS and in assessing and predicting 
treatment response, these results may be relevant to clinical practice. Therefore, we 
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propose using contrast-enhanced GRE sequences instead of SE sequences for routine 
scanning of MS patients at 3.0T. 
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Tables 
Table 1. Effect of the order in which sequences were acquired on the agreement 
between readers’ assessment and the reference standard 
  SE-GRE GRE-SE 
 TP 227.67 237.67 
 FP 8.0 8.67 
SE FN 75.33 66.33 
 Sensitivity 0.751 0.782 
 TP 255.67 250.0 
 FP 8.33 8.0 
GRE FN 48.33 57.0 
 Sensitivity 0.841 0.814 
GRE, gradient-echo; SE, spin-echo; TP, true positives; FP, false 
positives; FN, false negatives 
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Table 2. Agreement between the readers’ assessment and the reference standard 
  Reader 1 Reader 2 Reader 3 Mean 
 TP 481 (79.24) 475 (78.25) 440 (72.49) 465.33 (76.66) 
 FP 17 (2.80) 24 (3.95) 9 (1.48) 16.67 (2.75) 
SE FN 126 (20.76) 132 (21.75) 167 (27.51) 141.67 (23.34) 
 Total 624 631 616  
 Sensitivity 0.792 0.783 0.725 0.767 
 TP 508 (83.6) 499 (82.21) 498 (82.04) 501.67 (82.65) 
 FP 17 (2.80) 18 (2.97) 14 (2.31) 16.33 (2.69) 
GRE FN 99 (16.31) 108 (17.79) 109 (17.96) 105.33 (17.35) 
 Total 624 625 621  
 Sensitivity 0.838 0.823 0.822 0.828 
GRE, gradient-echo; SE, spin-echo; TP, true positives; FP, false positives; FN, 
false negatives 
*Values between parentheses represent the percentage of the total number of lesions 
identified in the reference standard. 
 22 
Table 3. Differentiability of the lesions detected 
 
 
 
Very 
poor 
Poor Fair Good Excellent 
  FN 51.33 
(8.46) 
42.33 
(6.97) 
30  
(4.94) 
11  
(1.81) 
7 
(1.15) 
SE Readers TP 17.67 
(2.91) 
36.67 
(6.04) 
64 
(10.54) 
103 
(16.97) 
244 
(40.20) 
  FP 3  
(0.49) 
5.33 
(0.88) 
7 
(1.15) 
0.67 
(0.11) 
0.67  
(0.11)  
 RS  69 
(11.37) 
79 
(13.01) 
94 
(15.49) 
114 
(18.78) 
251 
(41.35) 
  FN 56.33 
(9.28) 
21.67 
(3.57) 
18.33 
(3.02) 
6  
(0.99) 
4  
(0.66) 
GRE Readers TP 30.67 
(5.05) 
48.33 
(7.96) 
72.67 
(11.97) 
137 
(22.57) 
213 
(35.09) 
  FP 6  
(0.99) 
4.67 
(0.77) 
5.33 
(0.88)  
1.67 
(0.28) 
0.33  
(0.05) 
 RS  87 
(14.33) 
70 
(11.53) 
91 
(14.99) 
142 
(23.39) 
217 
(35.75) 
GRE, gradient-echo; SE, spin-echo; TP, true positives; FP, false positives; FN, 
false negatives; RS, reference standard 
*Values between parentheses represent the percentages of the total number of lesions 
identified in the reference standard 
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Table 4. Visual conspicuity indices of the lesions detected 
  CR3 CR5 CNR3 CNR5 
 FN 0.20 0.22 13.69 14.79 
SE TP 0.37 0.40 27.26 28.54 
 FP 0.25 0.29 14.85 16.32 
 FN 0.11 0.13 17.02 19.35 
GRE TP 0.23 0.26 37.76 40.61 
 FP 0.16 0.18 20.71 23.42 
CR3, contrast ratio with 3-pixel background; CR5, 
contrast ratio with 5-pixel background; CNR3, contrast-
to-noise ratio with 3-pixel background; CR5, contrast-to-
noise ratio with 5-pixel background; GRE, gradient-echo; 
SE, spin-echo; TP, true positives; FP, false positives; FN, 
false negatives 
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Table 5. Distance between detections in SE and GRE images 
  SE GRE 
  FN TP FP FN TP FP 
 FN 0.0 0.589 0.200 0.0 0.592 0.220 
CR3 TP 0.589 0.0 0.351 0.592 0.0 0.318 
 FP 0.200 0.351 0.0 0.220 0.318 0.0 
 FN 0.0 0.585 0.232 0.0 0.582 0.075 
CR5 TP 0.585 0.0 0.296 0.573 0.0 0.280 
 FP 0.232 0.296 0.0 0.234 0.280 0.0 
 FN 0.0 0.582 0.075 0.0 0.612 0.127 
CNR3 TP 0.582 0.0 0.550 0.612 0.0 0.450 
 FP 0.075 0.550 0.0 0.127 0.450 0.0 
 FN 0.0 0.572 0.093 0.0 0.600 0.131 
CNR5 TP 0.572 0.0 0.524 0.600 0.0 0.431 
 FP 0.093 0.524 0.0 0.131 0.431 0.0 
CR3, contrast ratio with 3-pixel background; CR5, contrast ratio with 5-pixel 
background; CNR3, contrast-to-noise ratio with 3-pixel background; CR5, 
contrast-to-noise ratio with 5-pixel background; GRE, gradient-echo; SE, spin-
echo; TP, true positives; FP, false positives; FN, false negatives 
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Figures  
 
 
 
Figure 1. Example of agreement between a reader and the reference standard for three 
slices. Spin-echo and gradient-recalled echo images are depicted in the top and bottom 
row, respectively. Each slice is shown in two columns. The left one shows the original 
images, and the right one an image with the type of detection in a color overlay (green, 
false negatives [FN], orange, true positives [TP], and red, false positives [FP]). 
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Figure 2. Effect of visual laterality on lesion detection. The left images show division 
of a representative image into four quadrants, numbered in red from 0 to 3 in the top 
image overlay. The number of lesions in the reference standard contained in each 
quadrant is shown in red overlay in the bottom image. The plots show the percentages 
of detection in each location, defined by the numbers associated with each quadrant, for 
spin-echo (top) and gradient recalled-echo (bottom) images. These plots represent the 
percentages normalized to the total number of false negative (FN) and true positive (TP) 
lesions per location.  
 
 
 
 
